Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors
Juwhan Choi, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Jae Jeong Shim, Sue In Choi, Dong Won Park, Chan Kwon Park, Eun Joo Kang, Hwan Seok Yong, Bong Kyung Shin, Hyun Koo Kim, Sung Yong Lee
Korean J Intern Med. 2022;37(1):127-136. Published online 2021 Jul 29 DOI: https://doi.org/10.3904/kjim.2020.011
Citations to this article as recorded by 
Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion
Zegang Ruan, Xin Zhuo, Chenyang Xu
Frontiers in Oncology.2024;[Epub] CrossRef
Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes
Xingping Zhang, Guijuan Zhang, Xingting Qiu, Jiao Yin, Wenjun Tan, Xiaoxia Yin, Hong Yang, Hua Wang, Yanchun Zhang
Biomarker Research.2024;[Epub] CrossRef
Surgically Treated pT2aN0M0 (Stage IB) Non-Small Cell Lung Cancer: A 20-Year Single-Center Retrospective Study
Monica Casiraghi, Francesco Petrella, Claudia Bardoni, Shehab Mohamed, Giulia Sedda, Juliana Guarize, Antonio Passaro, Filippo De Marinis, Patrick Maisonneuve, Lorenzo Spaggiari
Journal of Clinical Medicine.2023; 12(5): 2081. CrossRef
Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer
Ya-Fu Cheng, Yi-Ling Chen, Chia-Chi Liu, Ching-Min Lin, Shao-Syuan Tong, Bing-Yen Wang
Scientific Reports.2023;[Epub] CrossRef
Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
Zegui Tu, Tian Tian, Qian Chen, Caili Li, Yingming Sun
Journal of Oncology.2021; 2021: 1. CrossRef
A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion
Zegui Tu, Caili Li, Tian Tian, Qian Chen
Lung Cancer.2021; 161: 114. CrossRef